Position in CRNX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$3,095,626
-$524,334 QoQ
Shares Held
85,232
+9.6% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALPS ADVISORS INC holds $156,743,120 across 93 Biotechnology names. CRNX ranks #12 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
496,682 | $23,825,835 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
66,457 | $5,535,203 | |
| 3 | CGON |
CG Oncology, Inc.
|
68,737 | $4,652,120 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
49,128 | $4,538,444 | |
| 5 | CELC |
Celcuity Inc.
|
37,663 | $4,298,854 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
104,058 | $4,186,253 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
67,723 | $3,938,092 | |
| 8 | APGE |
Apogee Therapeutics, Inc.
|
45,586 | $3,836,973 |
All Filings in CRNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,095,626 | 85,232 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $3,619,960 | 77,765 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,974,834 | 47,415 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $1,453,070 | 50,524 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,257,342 | 67,303 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $3,833,983 | 74,985 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,103,967 | 60,743 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,755,704 | 61,525 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,573,098 | 54,969 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,637,569 | 46,025 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,199,354 | 40,328 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $715,574 | 39,710 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $570,451 | 35,520 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $667,529 | 36,477 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $575,962 | 29,326 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $591,951 | 31,740 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,071,489 | 48,815 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,561,527 | 54,964 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $998,527 | 47,436 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $933,376 | 49,516 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $910,122 | 59,563 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $838,656 | 59,437 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $657,105 | 41,934 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $785,053 | 44,809 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $647,388 | 44,040 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||